TABLE 1.

Characteristics of 28 GRE isolated at the University Hospital of Geneva

Patient	Isolate	Site	Date (mo/yr)	Warda	Genotypic identificationb	MIC (mg/liter)c		Glycopeptide genotype	PFGE pattern
						VA	TEI
1	1	Stool	8/94	Medecine	E. faecium	≥256	≥256	vanA	A1
2	2	Prosthesis	2/95	Orthopedics	E. faecium	≥256	64	vanA	B1
	3	Stool	3/95	Orthopedics	E. faecium	≥256	64	vanA	B2
3	4	Ulcer	3/95	Orthopedics	E. faecium	≥256	64	vanA	B1
	5	Stool	3/95	Orthopedics	E. faecium	≥256	64	vanA	B1
4	6	Stool	3/95	Hemat/onco	E. faecium	≥256	≥256	vanA	B3
5	7	Stool	6/95	Medecine	E. gallinarum	8	0.5	vanC1	C1
6	8	Stool	6/95	Surg/ICU	E. gallinarum	8	0.12	vanC1	D
7	9	Ascites	6/95	Surg/ICU	E. gallinarum	4	0.25	vanC1	E
8	10	Wound	9/95	Med/ICU	E. faecalis	64	4	vanA	F
9	11	Stool	9/95	Medecine	NR	≥256	0.25	vanA	Not done
10	12	Stool	10/95	Long-term H	E. faecium	≥256	4	vanA	A2
11	13	Stool	12/95	Surgery	E. faecium	≥256	64	vanA	G
12	14	Stool	12/95	Medecine	E. gallinarum	16	2	vanC1	H
13	15	Stool	1/96	Medecine	E. gallinarum	≥256	3	vanC1, vanB	I
14	16	Stool	1/96	Hemat/onco	E. gallinarum	16	0.2	vanC1	C1
15	17	Stool	2/96	Surg/ICU	E. gallinarum	8	0.25	vanC1	C2
16	18	Peritoneum	4/96	Surg/ICU	E. faecium	≥256	64	vanA	K
17	19	Peritoneum	5/96	Surg/ICU	E. faecium	≥256	64	vanA	B4
	20	Stool	7/96	Surg/ICU	E. faecium	≥256	64	vanA	B5
	21	Stool	7/96	Surg/ICU	E. faecalis	≥256	64	vanA	L
18	22	Urethra	5/96	Surg/ICU	E. faecium	≥256	64	vanA	B4
	23	Stool	6/96	Surg/ICU	E. faecalis	≥256	64	vanA	L
	24	Wound	7/96	Surg/ICU	E. faecalis	≥256	64	vanA	L
	25	Stool	7/96	Surg/ICU	E. faecium	≥256	64	vanA	B6
19	26	Stool	7/96	Hemat/onco	E. faecium	32	0.5	vanB	M1
	27	Stool	7/96	Hemat/onco	E. gallinarum	64	2	vanC1, vanB	N
	28	Gallbladder	9/96	Med/ICU	E. faecium	32	0.5	vanB	M2

^aHemat/onco, hematology-oncology; Med/ICU, medical intensive care unit; Surg/ICU, surgical intensive care unit; long-term H, long-term hospitalization unit. 

^bNR, no result obtained. 

^cVA, vancomycin; TEI, teicoplanin.